https://m2.mtmt.hu/ hun 2026-09-21 03:48 JournalArticle 32082299 VALIDATED true 0 false 2026-05-20T23:01:20.912+0000 2022-01-25T10:31:53.663+0000 2021-06-28T07:38:18.255+0000 true 10062250 Molnár-Taga Márta /api/admin/10062250 Admin Molnár-Taga Márta (SE 4-es admin) true 10062250 2023-09-26T10:50:43.530+0000 2023-09-26T10:50:43.530+0000 2022-01-25T10:31:53.672+0000 true 10062250 Molnár-Taga Márta /api/admin/10062250 Admin Molnár-Taga Márta (SE 4-es admin) true 10062250 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Garcia-Garcia, S. true true /api/journal/10019966 REVIEWED SCIENTIFIC REPORTS 2045-2322 true false 10019966 false 10019966 true 2045-2322 Journal FOREIGN 11 1 12287 12287 14 2021 Metastasis is the process of cancer cell dissemination from primary tumors to different organs being the bone the preferred site for metastatic homing of prostate cancer (PCa) cells. Prostate tumorigenesis is a multi-stage process that ultimately tends to advance to become metastatic PCa. Once PCa patients develop skeletal metastases, they eventually succumb to the disease. Therefore, it is imperative to identify essential molecular drivers of this process to develop new therapeutic alternatives for the treatment of this devastating disease. Here, we have identified MAP4K4 as a relevant gene for metastasis in PCa. Our work shows that genetic deletion of MAP4K4 or pharmacological inhibition of its encoded kinase, HGK, inhibits metastatic PCa cells migration and clonogenic properties. Hence, MAP4K4 might promote metastasis and tumor growth. Mechanistically, our results indicate that HGK depleted cells exhibit profound differences in F-actin organization, increasing cell spreading and focal adhesion stability. Additionally, HGK depleted cells fails to respond to TNF-α stimulation and chemoattractant action. Moreover, here we show that HGK upregulation in PCa samples from TCGA and other databases correlates with a poor prognosis of the disease. Hence, we suggest that it could be used as prognostic biomarker to predict the appearance of an aggressive phenotype of PCa tumors and ultimately, the appearance of metastasis. In summary, our results highlight an essential role for HGK in the dissemination of PCa cells and its potential use as prognostic biomarker. © 2021, The Author(s). Funding 2007699 /api/funding/2007699 Thematic Excellence Program (Semmelweis University)(2020-4.1.1.-TKP2020) Támogató: Innovációs és Technológiai Minisztérium false true true 2021 true true true false true false GOLD 2026-05-21 true https://doi.org/10.1038/s41598-021-91292-2 9 0 9 8 0 9 9 9 8 9 9 8 8 8 1 0 9 8 9 8 0 0 0 Folyóiratcikk Journal Article 24 9 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2022 0 2 2 2 2 2023 0 3 3 3 3 2024 0 2 1 2 1 2025 0 2 2 2 2 D1 A nemzetközi false false false false 2021-06-27T07:46:45.650+0000 Bioinformatika Tanszék (SE / AOK / I); II. Sz. Gyermekgyógyászati Klinika (SE / AOK / K); Onkológiai Biomarker Kutatócsoport (Lendület) (HRN TTK / MÉI) 1 26 3 9 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 96692221 /api/authorship/96692221 Garcia-Garcia, S. 1 0.11111111 true false false Garcia-Garcia S. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96692222 /api/authorship/96692222 Rodrigo-Faus, M.* 2 0.111 true false false Rodrigo-Faus M. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96692223 /api/authorship/96692223 Fonseca, N. 3 0.11111111 false false false Fonseca N. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96692224 /api/authorship/96692224 Manzano, S. 4 0.11111111 false false false Manzano S. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96692225 /api/authorship/96692225 Győrffy, B. [Győrffy, Balázs (Onkológia), szerző] II. Sz. Gyermekgyógyászati Klinika (SE / AOK / K); Onkológiai Biomarker Kutatócsoport (Lendület) (HRN TTK / MÉI); Bioinformatika Tanszék (SE / AOK / I) 5 0.111 false false false Author 10000109 /api/author/10000109 Győrffy Balázs (Onkológia) Győrffy Balázs true 10000109 true Győrffy B. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96692226 /api/authorship/96692226 Ocaña, A. 6 0.11111111 false false false Ocaña A. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96692227 /api/authorship/96692227 Bragado, P. 7 0.11111111 false false false Bragado P. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96692228 /api/authorship/96692228 Porras, A. 8 0.11111111 false false false Porras A. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96692229 /api/authorship/96692229 Gutierrez-Uzquiza, A. ✉ 9 0.11111111 false true true Gutierrez-Uzquiza A. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 18956373 /api/publicationidentifier/18956373 DOI: 10.1038/s41598-021-91292-2 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.1038/s41598-021-91292-2 https://doi.org/10.1038/s41598-021-91292-2 false true PublicationIdentifier 19065437 /api/publicationidentifier/19065437 WoS: 000663785600037 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000663785600037 https://www.webofscience.com/wos/woscc/full-record/000663785600037 true true PublicationIdentifier 18956372 /api/publicationidentifier/18956372 Scopus: 85107504975 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85107504975 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85107504975 false true PublicationIdentifier 18956374 /api/publicationidentifier/18956374 PubMed: 34112843 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 34112843 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34112843&dopt=Abstract false true MtaRating 519359 /api/mtarating/519359 IX. Szociológiai Tudományos Bizottság:A nemzetközi SCIENTIFIC REPORTS 2045-2322 RatingType 10007 /api/ratingtype/10007 IX. Szociológiai Tudományos Bizottság SZTB Institute 14102 /api/institute/14102 Szociológiai Tudományos Bizottság IXGJO SZTB [1901-] 0 false true false Szociológiai Tudományos Bizottság Committee on Sociology true 14102 true true true A nemzetközi true 19359 true MtaRating 11551161 /api/mtarating/11551161 IX. Regionális Tudományok Bizottsága:B nemzetközi SCIENTIFIC REPORTS 2045-2322 RatingType 10010 /api/ratingtype/10010 IX. Regionális Tudományok Bizottsága RegTB Institute 14100 /api/institute/14100 Regionális Tudományok Bizottsága IXGJO RTB [1901-] 0 false true false Regionális Tudományok Bizottsága Committee on Regional Studies true 14100 true true true B nemzetközi false true SjrRating 11184995 /api/sjrrating/11184995 sjr:D1 (2021) Scopus - Multidisciplinary SCIENTIFIC REPORTS 2045-2322 11 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1000 /api/classificationexternal/1000 Scopus - Multidisciplinary true 1000 true D1 DIRECT true true Reference 21464331 /api/reference/21464331 1. Kroon, J., Glycogen synthase kinase-3beta inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth (2014) Oncotarget, 5, pp. 8986-8994 1 false true Reference 21464330 /api/reference/21464330 2. Qadir, A.S., Msx2 is required for TNF-alpha-induced canonical Wnt signaling in 3T3-L1 preadipocytes (2011) Biochem. Biophys. Res. Commun., 408, pp. 399-404 2 false true Reference 21464329 /api/reference/21464329 3. Reya, T., Clevers, H., Wnt signalling in stem cells and cancer (2005) Nature, 434, pp. 843-850 3 false true Reference 21464328 /api/reference/21464328 4. Seetharaman, S., Etienne-Manneville, S., Cytoskeletal crosstalk in cell migration (2020) Trends Cell Biol., 30, pp. 720-735 4 false true Reference 21464327 /api/reference/21464327 5. Schaller, M.D., Biochemical signals and biological responses elicited by the focal adhesion kinase (2001) Biochim. Biophys. Acta, 1540, pp. 1-21 5 false true Reference 21464326 /api/reference/21464326 6. LeClaire, L.L., Rana, M., Baumgartner, M., Barber, D.L., The Nck-interacting kinase NIK increases Arp2/3 complex activity by phosphorylating the Arp2 subunit (2015) J. Cell Biol., 208, pp. 161-170 6 false true Reference 21464325 /api/reference/21464325 7. Someya, A., Moss, J., Nagaoka, I., The guanine nucleotide exchange protein for ADP-ribosylation factor 6, ARF-GEP100/BRAG2, regulates phagocytosis of monocytic phagocytes in an ARF6-dependent process (2010) J. Biol. Chem., 285, pp. 30698-30707 7 false true Reference 21464324 /api/reference/21464324 8. Morishige, M., GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion (2008) Nat. Cell Biol., 10, pp. 85-92 8 false true Reference 21464323 /api/reference/21464323 9. Hiroi, T., Someya, A., Thompson, W., Moss, J., Vaughan, M., GEP100/BRAG2: activator of ADP-ribosylation factor 6 for regulation of cell adhesion and actin cytoskeleton via E-cadherin and alpha-catenin (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 10672-10677 9 false true Reference 21464322 /api/reference/21464322 10. Dunphy, J.L., The Arf6 GEF GEP100/BRAG2 regulates cell adhesion by controlling endocytosis of beta1 integrins (2006) Curr. Biol., 16, pp. 315-320 10 false true Reference 21464321 /api/reference/21464321 11. Panetti, T.S., Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration (2002) Front. Biosci., 7, pp. d143-d150. , COI: 1:CAS:528:DC%2BD38Xit12nsrg%3D, PID: 11779709 11 false true Reference 21464320 /api/reference/21464320 12. Santhana Kumar, K., The Ser/Thr kinase MAP4K4 drives c-Met-induced motility and invasiveness in a cell-based model of SHH medulloblastoma (2015) Springerplus, 4, p. 19 12 false true Reference 21464319 /api/reference/21464319 13. Rizzardi, A.E., Evaluation of protein biomarkers of prostate cancer aggressiveness (2014) BMC Cancer, 14, p. 244 13 false true Reference 21464318 /api/reference/21464318 14. Tse, B.W., Scott, K.F., Russell, P.J., Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology (2012) Prostate Cancer, 2012, p. 128965 14 false true Reference 21464317 /api/reference/21464317 15. Koukouritaki, S.B., TNF-alpha induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase (1999) Mol. Med., 5, pp. 382-392. , COI: 1:CAS:528:DyaK1MXlslymu7w%3D 15 false true Reference 21464316 /api/reference/21464316 16. Yao, Z., A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway (1999) J. Biol. Chem., 274, pp. 2118-2125 16 false true Reference 21464315 /api/reference/21464315 17. what is special about bone? (2008) Cancer Metastasis Rev., 27, pp. 41-55 17 false true Reference 21464314 /api/reference/21464314 18. Bussard, K.M., Gay, C.V., Mastro, A.M., The bone microenvironment in metastasis 18 false true Reference 21464313 /api/reference/21464313 19. Liu, Y.F., Silencing of MAP4K4 by short hairpin RNA suppresses proliferation, induces G1 cell cycle arrest and induces apoptosis in gastric cancer cells (2016) Mol. Med. Rep., 13, pp. 41-48 19 false true Reference 21464312 /api/reference/21464312 20. Huang, H., MAP4K4 deletion inhibits proliferation and activation of CD4(+) T cell and promotes T regulatory cell generation in vitro (2014) Cell. Immunol., 289, pp. 15-20 20 false true Reference 21464311 /api/reference/21464311 21. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method (2001) Methods, 25, pp. 402-408 21 false true Reference 21464310 /api/reference/21464310 22. Prolo, L.M., Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion (2019) Sci. Rep., 9, p. 14020 22 false true Reference 21464309 /api/reference/21464309 23. Miao, W., Yuan, J., Li, L., Wang, Y., Parallel-reaction-monitoring-based proteome-wide profiling of differential kinase protein expression during prostate cancer metastasis in vitro (2019) Anal. Chem., 91, pp. 9893-9900 23 false true Reference 21464308 /api/reference/21464308 24. Yue, J., Microtubules regulate focal adhesion dynamics through MAP4K4 (2014) Dev. Cell, 31, pp. 572-585 24 false true Reference 21464307 /api/reference/21464307 25. Loftus, J.C., A novel interaction between Pyk2 and MAP4K4 is integrated with glioma cell migration (2013) J. Signal. Transduct., 2013, p. 956580 25 false true Reference 21464306 /api/reference/21464306 26. Tripolitsioti, D., MAP4K4 controlled integrin beta1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells (2018) Oncotarget, 9, pp. 23220-23236 26 false true Reference 21464305 /api/reference/21464305 27. Bai, Z., Yao, Q., Sun, Z., Xu, F., Zhou, J., Prognostic value of mRNA expression of MAP4K family in acute myeloid leukemia (2019) Technol. Cancer Res. Treat., 18 27 false true Reference 21464304 /api/reference/21464304 28. Qiu, M.H., Expression and prognostic significance of MAP4K4 in lung adenocarcinoma (2012) Pathol. Res. Pract., 208, pp. 541-548 28 false true Reference 21464303 /api/reference/21464303 29. Liang, J.J., Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma (2008) Clin. Cancer Res., 14, pp. 7043-7049 29 false true Reference 21464302 /api/reference/21464302 30. Hao, J.M., A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer (2010) J. Pathol., 220, pp. 475-489 30 false true Reference 21464301 /api/reference/21464301 31. Liu, A.W., ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth (2011) Clin. Cancer Res., 17, pp. 710-720 31 false true Reference 21464300 /api/reference/21464300 32. Zhao, G., miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4 (2013) Mol. Cancer Ther., 12, pp. 2569-2580 32 false true Reference 21464299 /api/reference/21464299 33. Gao, X., MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance (2017) Mol. Oncol., 11, pp. 628-639 33 false true Reference 21464298 /api/reference/21464298 34. Wright, J.H., The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion (2003) Mol. Cell. Biol., 23, pp. 2068-2082 34 false true Reference 21464297 /api/reference/21464297 35. Collins, C.S., A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 3775-3780 35 false true Reference 21464296 /api/reference/21464296 36. Tesz, G.J., Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2 (2007) J. Biol. Chem., 282, pp. 19302-19312 36 false true Reference 21464295 /api/reference/21464295 37. Faltermeier, C.M., Functional screen identifies kinases driving prostate cancer visceral and bone metastasis (2016) Proc. Natl. Acad. Sci. U. S. A., 113, pp. E172-E181 37 false true Reference 21464294 /api/reference/21464294 38. Gutierrez-Uzquiza, A., Lopez-Haber, C., Jernigan, D.L., Fatatis, A., Kazanietz, M.G., PKCε is an essential mediator of prostate cancer bone metastasis (2015) Mol. Cancer Res., 13, pp. 1336-1346 38 false true Reference 21464293 /api/reference/21464293 39. Weiner, A.B., Matulewicz, R.S., Eggener, S.E., Schaeffer, E.M., Increasing incidence of metastatic prostate cancer in the United States (2004–2013) (2016) Prostate Cancer Prostatic Dis., 19, pp. 395-397 39 false true Reference 21464292 /api/reference/21464292 40. Albala, D.M., Imaging and treatment recommendations in patients with castrate-resistant prostate cancer (2017) Rev. Urol., 19, pp. 200-202 40 false true /api/publication/32082299 Garcia-Garcia S. et al. HGK promotes metastatic dissemination in prostate cancer. (2021) SCIENTIFIC REPORTS 2045-2322 11 1<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <div class="autype autype0"> <span class="author-name" >Garcia-Garcia S. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Rodrigo-Faus M.^* </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Fonseca N. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Manzano S. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10000109"><a href="/gui2/?type=authors&mode=browse&sel=10000109" target="_blank">Győrffy B. (<span class="authorship-author-name">Győrffy Balázs</span> <span class="authorAux-mtmt"> Onkológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/II. Sz. Gyermekgyógyászati Klinika; <span title="Természettudományi Kutatóközpont">TTK</span>/<span title="Enzimológiai Intézet">EI</span>/Onkológiai Biomarker Kutatócsoport (Lendület); <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Bioinformatika Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Ocaña A. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Bragado P. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Porras A. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Gutierrez-Uzquiza A. ✉ </span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;32082299" target="_blank">HGK promotes metastatic dissemination in prostate cancer</a></div> <div> <span class="journal-title">SCIENTIFIC REPORTS</span> <span class="journal-issn">( <a target="_blank" href="https://portal.issn.org/resource/ISSN/2045-2322">2045-2322</a>)</span>: <span class="journal-volume">11</span> <span class="journal-issue">1</span> <span class="page"> Paper 12287. 14 p. </span> <span class="year">(2021)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.1038/s41598-021-91292-2" target="_blank" href="https://doi.org/10.1038/s41598-021-91292-2"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000663785600037" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000663785600037"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85107504975" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85107504975"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="34112843" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34112843&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Multidisciplinary&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Szociológiai Tudományos Bizottság IXGJO SZTB [1901-]&nbsp;&nbsp;&nbsp;A nemzetközi</div> <div class="journal-subject">Regionális Tudományok Bizottsága IXGJO RTB [1901-]&nbsp;&nbsp;&nbsp;B nemzetközi</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 9</span> | Független: 8 | Függő: 1 | Nem jelölt: 0 | WoS jelölt: 9 | Scopus jelölt:&nbsp;8 | WoS/Scopus jelölt:&nbsp;9 | DOI jelölt:&nbsp;9 </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 32082299</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">Scopus</span> </div> <div class="funder"> Thematic Excellence Program (Semmelweis University)(2020-4.1.1.-TKP2020) Támogató: Innovációs és Technológiai Minisztérium </div> <div class="lastModified">Utolsó módosítás: 2022.01.25. 11:31 Molnár-Taga Márta (SE 4-es admin) </div> </div></div>